Recall
FDAHealthMay 29, 2025

Eugia US LLC — Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Ca

⚠️ Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
May 29, 2025

Nationwide in the USA

What's affected?

Product
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
Lot code
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025

Additional details

Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 48,000 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.